Share the article
twitter-iconcopy-link-iconprint-icon
share-icon
Western EuropeApril 6 2009

Roche's perfect storm

Drug company Roche made a rare foray into the markets recently, with BNP Paribas being among the bookrunners putting together its record-breaking euro bond deal to finance the purchase of US biotech firm Genentech. Writer Edward Russell-Walling
Share the article
twitter-iconcopy-link-iconprint-icon
share-icon
Left to right: Christoph Seibel, Frederic Zorzi and Rupert Lewis

Left to right: Christoph Seibel, Frederic Zorzi and Rupert Lewis

Was this article helpful?

Thank you for your feedback!

Read more about:  Analysis & opinion , Banking strategies , Comment , Deals , Western Europe , Switzerland

Latest from Western Europe

European NPLs on the rise again
Databank
APRIL 26
UK banks warned of significant impact from nature-related risks
ESG & sustainability
APRIL 25
FCA launches review into Big Tech data
Regulations
APRIL 24
The Banker’s Top 30 Nordic Banks 2024
Best-performing banks
APRIL 24
UK regulator urges banks to stress test their private equity exposure
Regulations
APRIL 23

Trending in The Banker

  1. Fintech doesn’t deserve trite, tech-bro speak

    Editor’s blog
    APRIL 17

  2. ‘The most British of foreign banks’

    Agenda
    APRIL 15

  3. Canada announces date for real-time payments system launch

    Digital journeys
    APRIL 18

  4. Ripple to launch USD-pegged stablecoin on XRP ledger and Ethereum

    Crypto assets
    APRIL 5

  5. The Banker’s Top 100 US Banks 2024

    Best-performing banks
    APRIL 3
A service from the Financial Times